Annual CFI
$48.97 M
+$48.97 M+100.00%
31 December 2023
Summary:
Leap Therapeutics annual cash flow from investing activities is currently $48.97 million, with the most recent change of +$48.97 million (+100.00%) on 31 December 2023. During the last 3 years, it has risen by +$48.94 million (+195776.00%). LPTX annual CFI is now at all-time high.LPTX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$0.00
$0.000.00%
30 September 2024
Summary:
Leap Therapeutics quarterly cash flow from investing activities is currently $0.00, unchanged on 30 September 2024. Over the past year, it has stayed the same.LPTX quarterly CFI is now -100.00% below its all-time high of $49.32 million, reached on 31 March 2023.LPTX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
$0.00
$0.000.00%
30 September 2024
Summary:
Leap Therapeutics TTM cash flow from investing activities is currently $0.00, unchanged on 30 September 2024. Over the past year, it has dropped by -$48.97 million (-100.00%). LPTX TTM CFI is now -100.00% below its all-time high of $49.32 million, reached on 31 March 2023.LPTX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LPTX Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +100.0% | 0.0% | -100.0% |
| 3 y3 years | +10000.0% | - | - |
| 5 y5 years | +100.0% | 0.0% | +100.0% |
LPTX Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | -100.0% | +100.0% | -100.0% | +100.0% | |
| 5 y | 5 years | at high | >+9999.0% | -100.0% | +100.0% | -100.0% | +100.0% |
| alltime | all time | at high | +233.1% | -100.0% | +100.0% | -100.0% | +100.0% |
Leap Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2024 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 2024 | - | $0.00(0.0%) | -$348.00 K(-100.7%) |
| Dec 2023 | $48.97 M(>+9900.0%) | $0.00(0.0%) | $48.97 M(0.0%) |
| Sept 2023 | - | $0.00(-100.0%) | $48.97 M(0.0%) |
| June 2023 | - | -$348.00 K(-100.7%) | $48.97 M(-0.7%) |
| Mar 2023 | - | $49.32 M(>+9900.0%) | $49.32 M(>+9900.0%) |
| Dec 2022 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2022 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2020 | $25.00 K(-129.4%) | $0.00(0.0%) | $25.00 K(-37.5%) |
| Sept 2020 | - | $0.00(-100.0%) | $40.00 K(0.0%) |
| June 2020 | - | $25.00 K(+66.7%) | $40.00 K(-147.1%) |
| Dec 2019 | -$85.00 K(<-9900.0%) | $15.00 K(>+9900.0%) | -$85.00 K(-15.0%) |
| Sept 2019 | - | $0.00(-100.0%) | -$100.00 K(0.0%) |
| June 2019 | - | -$100.00 K(<-9900.0%) | -$100.00 K(<-9900.0%) |
| Dec 2018 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2018 | - | $0.00(0.0%) | $0.00(-100.0%) |
| June 2018 | - | $0.00(0.0%) | $2000.00(-103.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | -$64.00 K(-55.6%) | $0.00(-100.0%) | -$64.00 K(-11.1%) |
| Sept 2017 | - | $2000.00(-300.0%) | -$72.00 K(-2.7%) |
| June 2017 | - | -$1000.00(-98.5%) | -$74.00 K(-58.7%) |
| Mar 2017 | - | -$65.00 K(+712.5%) | -$179.00 K(+24.3%) |
| Dec 2016 | -$144.00 K(<-9900.0%) | -$8000.00(<-9900.0%) | -$144.00 K(-99.2%) |
| Sept 2016 | - | $0.00(-100.0%) | -$17.41 M(+71.3%) |
| June 2016 | - | -$106.00 K(+253.3%) | -$10.16 M(+48.2%) |
| Mar 2016 | - | -$30.00 K(-99.8%) | -$6.86 M(<-9900.0%) |
| Dec 2015 | $0.00(-100.0%) | -$17.27 M(-338.4%) | $0.00(-100.0%) |
| Sept 2015 | - | $7.25 M(+126.4%) | -$11.81 M(-55.7%) |
| June 2015 | - | $3.20 M(-53.1%) | -$26.68 M(-10.8%) |
| Mar 2015 | - | $6.83 M(-123.5%) | -$29.91 M(-18.7%) |
| Dec 2014 | -$36.80 M(>+9900.0%) | -$29.09 M(+281.7%) | -$36.80 M(+374.0%) |
| Sept 2014 | - | -$7.62 M(>+9900.0%) | -$7.76 M(+4974.5%) |
| June 2014 | - | -$27.00 K(-63.0%) | -$153.00 K(-15.5%) |
| Mar 2014 | - | -$73.00 K(+62.2%) | -$181.00 K(+58.8%) |
| Dec 2013 | -$114.00 K(-16.2%) | -$45.00 K(+462.5%) | -$114.00 K(+65.2%) |
| Sept 2013 | - | -$8000.00(-85.5%) | -$69.00 K(+13.1%) |
| June 2013 | - | -$55.00 K(+816.7%) | -$61.00 K(+916.7%) |
| Mar 2013 | - | -$6000.00 | -$6000.00 |
| Dec 2012 | -$136.00 K | - | - |
FAQ
- What is Leap Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Leap Therapeutics?
- What is Leap Therapeutics annual CFI year-on-year change?
- What is Leap Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Leap Therapeutics?
- What is Leap Therapeutics quarterly CFI year-on-year change?
- What is Leap Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Leap Therapeutics?
- What is Leap Therapeutics TTM CFI year-on-year change?
What is Leap Therapeutics annual cash flow from investing activities?
The current annual CFI of LPTX is $48.97 M
What is the all time high annual CFI for Leap Therapeutics?
Leap Therapeutics all-time high annual cash flow from investing activities is $48.97 M
What is Leap Therapeutics annual CFI year-on-year change?
Over the past year, LPTX annual cash flow from investing activities has changed by +$48.97 M (+100.00%)
What is Leap Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of LPTX is $0.00
What is the all time high quarterly CFI for Leap Therapeutics?
Leap Therapeutics all-time high quarterly cash flow from investing activities is $49.32 M
What is Leap Therapeutics quarterly CFI year-on-year change?
Over the past year, LPTX quarterly cash flow from investing activities has changed by $0.00 (0.00%)
What is Leap Therapeutics TTM cash flow from investing activities?
The current TTM CFI of LPTX is $0.00
What is the all time high TTM CFI for Leap Therapeutics?
Leap Therapeutics all-time high TTM cash flow from investing activities is $49.32 M
What is Leap Therapeutics TTM CFI year-on-year change?
Over the past year, LPTX TTM cash flow from investing activities has changed by -$48.97 M (-100.00%)